New Drug Reviews

Here at Ventegra, we are committed to providing our clients with the information they need to make the important decisions they face daily. To help our clients, Ventegra’s Clinical Programs department is pleased to provide this new feature that is designed to give an overview of timely information regarding clinical information related to the latest FDA-approvals.

While these reviews offer a starting point for learning about new drugs, it is essential that practitioners be aware of changes in a drug's therapeutic profile as reported in the pharmaceutical literature.

The new drug review document will be available here for 180 days from the posting date, then it will be archived. For any questions, you may contact Clinical Programs at clinical@ventegra.com.